NEWRON PHARMA N/ IT0004147952 /
9/5/2024 5:30:13 PM | Chg. -0.650 | Volume | Bid8:46:52 PM | Ask8:46:52 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.830CHF | -7.67% | 155,092 Turnover: 1.23 mill. |
7.600Bid Size: 1,500 | 8.500Ask Size: 2,300 | 139.73 mill.CHF | - | - |
Assets
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
Intangible Assets | 5.2000 | 11.2000 | 9.1000 | 7 | .3000 | ||||||
Long-Term Investments | .6000 | .6000 | .6000 | .6000 | 0.0000 | ||||||
Fixed Assets | 5.9000 | 11.9000 | 9.8000 | 7.7000 | .4000 | ||||||
Inventories | .2000 | .2000 | .3000 | .1000 | 0.0000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 5.4000 | 29.2000 | 18.4000 | 18.8000 | 36 | ||||||
Current Assets | 7.6000 | 32.7000 | 21.8000 | 29.4000 | 44 | ||||||
Total Assets | 13.6000 | 44.7000 | 31.6000 | 37.1000 | 44.4000 |
Liabilities
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 2.4000 | 6.3000 | 3.7000 | 3.8000 | 6.2000 | ||||||
Long-term debt | 1.8000 | 1.4000 | 1.1000 | .7000 | .4000 | ||||||
Liabilities to Banks | 2.2000 | 1.8000 | 1.5000 | 1.1000 | .8000 | ||||||
Provisions | 1.7000 | 3.5000 | 2.9000 | 2.3000 | .1000 | ||||||
Liabilities | 7 | 17 | 10.5000 | 7.8000 | 7.3000 | ||||||
Share Capital | 1.5000 | 2.3000 | 2.3000 | 2.6000 | 2.8000 | ||||||
Total Equity | 6.6000 | 27.6000 | 21.1000 | 29.3000 | 37.1000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 13.6000 | 44.7000 | 31.6000 | 37.1000 | 44.4000 |
Income Statement
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.3000 | 8.9000 | 3.5000 | 1.6000 | 2.4000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -6.5000 | -2.7000 | -7.8000 | -11.2000 | -24.4000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -6.4000 | -2.5000 | -7.7000 | -10.7000 | -25 | ||||||
Income Taxes | 0.0000 | .1000 | .6000 | .6000 | 2.2000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -6.4000 | -2.4000 | -7.1000 | -10.1000 | -22.8000 |
Per Share
Cash Flow
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -4.9000 | 5.8000 | -10.7000 | -10 | -12.9000 | ||||||
Cash Flow from Investing Activities | .1000 | 10 | .2000 | -6.9000 | 2.1000 | ||||||
Cash Flow from Financing | 2.2000 | 8 | -.4000 | 17.2000 | 28 | ||||||
Decrease / Increase in Cash | -2.7000 | 23.9000 | -10.8000 | .3000 | 17.3000 | ||||||
Employees | 31 | 23 | 23 | 23 | 23 |